{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T13:37:08Z","timestamp":1758893828855,"version":"3.44.0"},"reference-count":34,"publisher":"BMJ","issue":"2","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Frontline Gastroenterol"],"accepted":{"date-parts":[[2013,10,2]]},"published-print":{"date-parts":[[2014,4]]},"abstract":"<jats:p>Alcoholic liver disease (ALD) is increasing in incidence in the UK. It is the commonest cause of liver-related deaths, predominantly in people below the age of 60. Alcoholic hepatitis (AH) is an acute form of ALD with high mortality when severe. Jaundice and coagulopathy are clinical hallmarks of severe AH. Histology findings are characterised by parenchymal inflammation and hepatocellular damage although biopsy is only required when diagnostic uncertainty exists; clinical findings are usually sufficient for accurate diagnosis. Patients with AH should be stratified as non-severe or severe using non-invasive scoring systems such as the discriminant function or the Glasgow Alcoholic Hepatitis Score. In patients with non-severe AH, abstinence is the mainstay of treatment, and it is important that steps are taken to help patients stop drinking. Severe AH requires specialist treatment. Consensus guidelines recommend the use of prednisolone although this remains subject to clinical trials. Pentoxifylline may have a survival benefit if corticosteroids are contraindicated. Nutritional support and N-acetylcysteine should be considered for use in conjunction with corticosteroids although evidence of benefit is not conclusive. Patients with severe disease who do not respond to therapy within a week have a very poor outcome. Recent data have shown a survival benefit of liver transplantation in this group although this remains experimental at present. Current and future research should focus on targeted therapies for severe AH and those who fail first-line treatment.<\/jats:p>","DOI":"10.1136\/flgastro-2013-100373","type":"journal-article","created":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T22:06:09Z","timestamp":1383343569000},"page":"123-129","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":3,"title":["Diagnosis and treatment of alcoholic hepatitis"],"prefix":"10.1136","volume":"5","author":[{"given":"R","family":"Parker","sequence":"first","affiliation":[{"name":"NIHR Centre for Liver Research, University of Birmingham, Birmingham, UK"},{"name":"Liver Unit, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C A","family":"McCune","sequence":"additional","affiliation":[{"name":"Department of Liver Medicine, University Hospitals Bristol NHS Foundation Trust, Bristol, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2013,11,1]]},"reference":[{"doi-asserted-by":"publisher","key":"2025090708102139000_5.2.123.1","DOI":"10.1016\/S0140-6736(06)67924-5"},{"unstructured":"National Institute for Healthcare and Clinical Excellence. Measuring the units: a review of patients who died with alcohol related liver disease. 2013.","key":"2025090708102139000_5.2.123.2"},{"key":"2025090708102139000_5.2.123.3","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.jhep.2012.04.004","article-title":"EASL Clinical Practical Guidelines: management of alcoholic liver disease","volume":"57","year":"2012","journal-title":"J Hepatol"},{"doi-asserted-by":"publisher","key":"2025090708102139000_5.2.123.4","DOI":"10.1136\/gut.2010.224097"},{"doi-asserted-by":"publisher","key":"2025090708102139000_5.2.123.5","DOI":"10.1002\/hep.23258"},{"unstructured":"National Institute for Healthcare and Clinical Excellence. Diagnosis and clinical management of alcohol related physical complications. 2010.","key":"2025090708102139000_5.2.123.6"},{"doi-asserted-by":"publisher","key":"2025090708102139000_5.2.123.7","DOI":"10.1111\/j.1530-0277.2008.00827.x"},{"doi-asserted-by":"publisher","key":"2025090708102139000_5.2.123.8","DOI":"10.1053\/j.gastro.2011.09.002"},{"key":"2025090708102139000_5.2.123.9","doi-asserted-by":"crossref","first-page":"5504","DOI":"10.3748\/wjg.v18.i39.5504","article-title":"Molecular targets in the treatment of alcoholic hepatitis","volume":"18","author":"Dhanda","year":"2012","journal-title":"World J Gastroenterol"},{"key":"2025090708102139000_5.2.123.10","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.3748\/wjg.v16.i19.2435","article-title":"Early mortality of alcoholic hepatitis: a review of data from placebo-controlled clinical trials","volume":"16","author":"Yu","year":"2010","journal-title":"World J Gastroenterol"},{"doi-asserted-by":"publisher","key":"2025090708102139000_5.2.123.11","DOI":"10.1056\/NEJMra0805786"},{"key":"2025090708102139000_5.2.123.12","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.cgh.2011.09.011","article-title":"Acute kidney injury is an early predictor of mortality for patients with alcoholic hepatitis","volume":"10","author":"Altamirano","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"doi-asserted-by":"publisher","key":"2025090708102139000_5.2.123.13","DOI":"10.1001\/archinte.158.16.1789"},{"doi-asserted-by":"publisher","key":"2025090708102139000_5.2.123.14","DOI":"10.1093\/alcalc\/37.1.61"},{"unstructured":"National Institute for Healthcare and Clinical Excellence. Alcohol use disorders: diagnosis, assessment, and management of harmful drinking and alcohol dependence. 2011.","key":"2025090708102139000_5.2.123.15"},{"key":"2025090708102139000_5.2.123.16","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1002\/lt.21528","article-title":"Detecting lifetime alcohol problems in individuals referred for liver transplantation for nonalcoholic liver failure","volume":"14","author":"Day","year":"2008","journal-title":"Liver Transpl"},{"key":"2025090708102139000_5.2.123.17","doi-asserted-by":"crossref","first-page":"966","DOI":"10.3748\/wjg.v16.i8.966","article-title":"Increased liver stiffness in alcoholic liver disease: differentiating fibrosis from steatohepatitis","volume":"16","author":"Mueller","year":"2010","journal-title":"World J Gastroenterol"},{"key":"2025090708102139000_5.2.123.18","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1111\/apt.12414","article-title":"The management of alcoholic hepatitis: a prospective comparison of scoring systems","volume":"38","author":"Lafferty","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"doi-asserted-by":"publisher","key":"2025090708102139000_5.2.123.19","DOI":"10.1136\/gut.2006.099226"},{"key":"2025090708102139000_5.2.123.20","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1007\/s10620-006-9099-z","article-title":"Prevalence of septic events, type 1 hepatorenal syndrome, and mortality in severe alcoholic hepatitis and utility of discriminant function and meld score in predicting these adverse events","volume":"51","author":"Verma","year":"2006","journal-title":"Dig Dis Sci"},{"doi-asserted-by":"publisher","key":"2025090708102139000_5.2.123.21","DOI":"10.1136\/gut.2009.189639"},{"key":"2025090708102139000_5.2.123.22","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1053\/j.gastro.2009.04.062","article-title":"Infection in patients with severe alcoholic hepatitis treated with steroids: Early response to therapy is the key factor","volume":"137","author":"Louvet","year":"2009","journal-title":"Gastroenterology"},{"key":"2025090708102139000_5.2.123.23","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1111\/apt.12279","article-title":"Systematic review: pentoxifylline for the treatment of severe alcoholic hepatitis","volume":"37","author":"Parker","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"doi-asserted-by":"publisher","key":"2025090708102139000_5.2.123.24","DOI":"10.1053\/jhep.2000.8627"},{"doi-asserted-by":"publisher","key":"2025090708102139000_5.2.123.25","DOI":"10.1016\/j.jhep.2005.11.039"},{"doi-asserted-by":"publisher","key":"2025090708102139000_5.2.123.26","DOI":"10.1016\/j.jhep.2010.05.030"},{"doi-asserted-by":"publisher","key":"2025090708102139000_5.2.123.27","DOI":"10.1056\/NEJMoa1101214"},{"doi-asserted-by":"publisher","key":"2025090708102139000_5.2.123.28","DOI":"10.1056\/NEJMoa1105703"},{"doi-asserted-by":"crossref","unstructured":"Forrest E Mellor J Stanton L . Steroids or pentoxifylline for alcoholic hepatitis (STOPAH): study protocol for a randomised controlled trial. Trials 2013;14. doi:10.1186\/1745-6215-14-262","key":"2025090708102139000_5.2.123.29","DOI":"10.1186\/1745-6215-14-262"},{"key":"2025090708102139000_5.2.123.30","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1002\/hep.23666","article-title":"Theophylline improves steroid sensitivity in acute alcoholic hepatitis","volume":"52","author":"Kendrick","year":"2010","journal-title":"Hepatology"},{"key":"2025090708102139000_5.2.123.31","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1002\/hep.24159","article-title":"In vitro steroid resistance correlates with outcome in severe alcoholic hepatitis","volume":"53","author":"Di Mambro","year":"2011","journal-title":"Hepatology"},{"unstructured":"Assess Safety and Efficacy of ELAD (extracorporeal Liver Assist System) in Subjects With Alcohol-induced Liver Failure Clincial Trial Identifier NCT01471028. http:\/\/www.clinicaltrials.gov (accessed 27 Aug 2013).","key":"2025090708102139000_5.2.123.32"},{"key":"2025090708102139000_5.2.123.33","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1097\/MEG.0b013e328332a360","article-title":"Granulocytapheresis in the treatment of severe alcoholic hepatitis: a case series","volume":"22","author":"Morris","year":"2010","journal-title":"Eur J Gastroenterol Hepatol"},{"doi-asserted-by":"publisher","key":"2025090708102139000_5.2.123.34","DOI":"10.1371\/journal.pone.0053719"}],"container-title":["Frontline Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/flgastro-2013-100373","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T15:10:32Z","timestamp":1757257832000},"score":1,"resource":{"primary":{"URL":"https:\/\/fg.bmj.com\/lookup\/doi\/10.1136\/flgastro-2013-100373"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11,1]]},"references-count":34,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2014,2,28]]},"published-print":{"date-parts":[[2014,4]]}},"alternative-id":["10.1136\/flgastro-2013-100373"],"URL":"https:\/\/doi.org\/10.1136\/flgastro-2013-100373","relation":{},"ISSN":["2041-4137","2041-4145"],"issn-type":[{"type":"print","value":"2041-4137"},{"type":"electronic","value":"2041-4145"}],"subject":[],"published":{"date-parts":[[2013,11,1]]}}}